Clinical trials
Phase 1 Lymphoma, Non-Hodgkin trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 7 |
| 2020 | 6 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 3 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 48 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Timmune Biotech Inc. | 3 |
| Institute of Hematology & Blood Diseases Hospital, China | 2 |
| Jonsson Comprehensive Cancer Center | 2 |
| University of California, Davis | 2 |
| Zhejiang University | 2 |
| Anhui Provincial Hospital | 1 |
| Ascentage Pharma Group Inc. | 1 |
| Athenex, Inc. | 1 |
| Beijing Immunochina Medical Science & Technology Co., Ltd. | 1 |
| Bioray Laboratories | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Non-Hodgkin | 48 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 17 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 13 |
| Lymphoma | 10 |
| Lymphoma, B-Cell | 9 |
| Lymphoma, Follicular | 9 |
| Recurrence | 9 |
| Burkitt Lymphoma | 8 |
| Lymphoma, B-Cell, Marginal Zone | 8 |
| Lymphoma, Large B-Cell, Diffuse | 8 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.